Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patients in Sohag University Hospital
NCT07119905 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-08-13
Summary
The goal of this observational study is to investigate the potential association between MMP-9 gene polymorphism and susceptibility to Primary Open Angle Glaucoma development in Egyptian patients The main question it aims to
Conditions
- Primary Open Angle Glaucoma (POAG)
Interventions
- GENETIC
-
genotyping assay by polymerase chain reaction
Blood sample will be obtained from all participants by withdrawing 3 mL of blood via venipuncture in ethylenediaminetetraacetic acid tube. Thereafter, DNA extraction will be obtained after centrifugation to be used for genotyping assay of MMP-9 gene with polymerase chain reaction
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2027-01-01
- Completion
- 2027-02-01
Countries
- Egypt
Study Locations
More Related Trials
-
Multicentric Observational Study on Quality of Life in Glaucoma
NCT01742104 ·Status: COMPLETED
-
Anterior Chamber Angle Examination in Angle Closure Suspect Patients
NCT05209204 ·Status: COMPLETED
-
Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors
NCT03293251 ·Status: UNKNOWN
-
Social History and Glaucoma Progression
NCT06434155 ·Status: COMPLETED
-
AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification
NCT05332665 ·Status: UNKNOWN
-
VEGF in Iris Tissue in Primary Congenital Glaucoma
NCT05484050 ·Status: UNKNOWN ·Phase: NA
-
Comparison Between Anterior Segment Optical Coherence Tomography and Ultrasound Bio Microscopy Parameters in Glaucoma Assessment
NCT05730478 ·Status: ACTIVE_NOT_RECRUITING
-
Central Corneal Thickness in Glaucoma
NCT01023997 ·Status: COMPLETED
-
Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)
NCT01540370 ·Status: COMPLETED
-
Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients
NCT01025024 ·Status: COMPLETED
-
Saccadic Eye Movements Are Impaired In Glaucoma
NCT01254058 ·Status: UNKNOWN
-
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma
NCT03423758 ·Status: RECRUITING
-
Optical Coherence Tomography of the Irido-Corneal Angle Before and After Goniotomy and Trabeculotomy in Primary Congenital Glaucoma
NCT07012252 ·Status: COMPLETED ·Phase: NA
-
Phaco-Trabeculotomy Vs Phaco-Trabeculectomy
NCT04683055 ·Status: COMPLETED ·Phase: NA
-
mRNA Expression in Lymphocytes of Glaucoma Patients
NCT00327509 ·Status: COMPLETED
-
Progressive Open Angle Glaucoma (OAG) and Ocular Blood Flow
NCT00912470 ·Status: WITHDRAWN ·Phase: NA
-
Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy
NCT03626675 ·Status: UNKNOWN ·Phase: NA
-
Correlation Between Angle Closure Glaucoma Data and Lens Zonule Status
NCT06184620 ·Status: COMPLETED
-
Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans
NCT02989207 ·Status: UNKNOWN ·Phase: NA
-
CPC in Adult Refractory Glaucoma
NCT04921098 ·Status: UNKNOWN ·Phase: NA
-
Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications
NCT01511094 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients
NCT07152132 ·Status: RECRUITING ·Phase: NA
-
Patterns of Glaucoma in Glaucoma Subspecialty Clinics in Egypt and India in the Year 2018
NCT03491735 ·Status: UNKNOWN
-
Prophylactic Peripheral Iridectomy Prevents Aphakic Angle-closure Glaucoma
NCT03610295 ·Status: COMPLETED ·Phase: NA
-
Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma
NCT04455126 ·Status: COMPLETED ·Phase: PHASE2/PHASE3